SYNLAB AG provides clinical laboratory and medical diagnostic services for insurance companies, hospitals, pharmacies, national health organizations, practicing doctors, clinics, patients, governments, and corporations primarily in Europe. The company offers Coronavirus tests, and medical and veterinary diagnostics services. It operates through approximately 500 laboratories and 1,800 blood collection points in 36 countries in four continents. The company was founded in 1998 and is headquartered in Munich, Germany.
Revenue of SYNLAB AG (SYAB.DE)
Revenue in 2023 (TTM): $2.78 B
According to SYNLAB AG's latest financial reports the company's current revenue (TTM) is $2.78 B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of SYNLAB AG
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $2.78 B | $601.18 M | $434.02 M | $150.9 M | $97.34 M |
| 2022 | $3.43 B | $2.61 B | $1.02 B | $298.52 M | $158.97 M |
| 2021 | $3.97 B | $2.98 B | $1.26 B | $849.87 M | $659.07 M |
| 2020 | $2.77 B | $2.04 B | $821.37 M | $132.13 M | $40.02 M |
| 2019 | $2.01 B | $1.55 B | $278.56 M | $-99,815,631 | $-128,558,777 |
| 2018 | $1.91 B | $1.47 B | $274.62 M | $-20,586,578 | $-54,083,151 |
| 2017 | $1.92 B | $1.5 B | $311.52 M | $-152,858,641 | $-174,665,751 |
| 2016 | $1.66 B | $1.29 B | $295.58 M | $-213,883,103 | $-243,052,433 |
| 2015 | $891.09 M | $686.96 M | $142.41 M | $-162,439,365 | $-178,154,520 |